CU BO CURCUMIN BOSWELLIA
LIVE

Serial Number

79381593

Owner

INDENA S.p.A

Attorney

Robert S. Broder

Filing Date

Sep 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CU BO CURCUMIN BOSWELLIA Trademark

Serial Number: 79381593 • Registration: 7942998

CU BO CURCUMIN BOSWELLIA is a trademark filed by INDENA S.p.A on September 8, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

INDENA S.p.A

Viale Ortles 12

Entity Type: 35

Trademark Details

Filing Date

September 8, 2023

Registration Date

September 16, 2025

Published for Opposition

July 29, 2025

Goods & Services

Pharmaceutical preparations for the treatment of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome diseases, all containing curcumin and boswellia; dietary supplements and dietetic preparations, all containing curcumin and boswellia; Plant and herb extracts, other than essential oils, for medicinal purposes, all containing curcumin and boswellia.

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, dietary supplements and dietetic preparations, all containing curcumin and boswellia; Chemical preparations for the manufacture of pharmaceuticals, dietary supplements and dietetic preparations, for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, all containing curcumin and boswellia; Chemical additives for use in the manufacture of food, all containing curcumin and boswellia.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 16, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 27, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 27, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 16, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 16, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2025 TROA
REFUSAL PROCESSED BY IB
May 3, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 15, 2025 RFRR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 25, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 25, 2025 OPNR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 30, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 29, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
May 24, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 16, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 15, 2024 CNRT
ASSIGNED TO EXAMINER
May 3, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 31, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 26, 2023 REPR